Association study of tardive dyskinesia and twelve DRD2 polymorphisms in schizophrenia patients (Q46422249)

22 December 2017

title

Association study of tardive dyskinesia and twelve DRD2 polymorphisms in schizophrenia patients (English)

1 reference

22 December 2017

0 references

1 reference

10

1 reference

22 December 2017

Gary Remington

7

Gary Remington

1 reference

22 December 2017

Jeffrey Lieberman

9

Jeffrey A Lieberman

1 reference

22 December 2017

James L. Kennedy

11

James L Kennedy

1 reference

22 December 2017

Nicole King

5

Nicole King

1 reference

22 December 2017

Clement C. Zai

1

0 references

Herbert Y. Meltzer

8

0 references

Daniel J. Müller

4

Daniel J Müller

1 reference

22 December 2017

Gwyneth C M Zai

6

Gwyneth C Zai

1 reference

22 December 2017

Rudi W Hwang

2

Rudi W Hwang

1 reference

22 December 2017

author name string

Vincenzo De Luca

3

1 reference

22 December 2017

publication date

7 September 2006

1 reference

22 December 2017

The International Journal of Neuropsychopharmacology

published in

1 reference

22 December 2017

volume

10

1 reference

22 December 2017

issue

5

1 reference

22 December 2017

page(s)

639-651

1 reference

22 December 2017

Conventional vs. newer antipsychotics in elderly patients

cites work

1 reference

https://api.crossref.org/works/10.1017%2FS1461145706007152

Homozygosity for the Gly-9 variant of the dopamine D3 receptor and risk for tardive dyskinesia in schizophrenic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145706007152

Association between the Ser9Gly polymorphism of the dopamine D3 receptor gene and tardive dyskinesia in Chinese schizophrenic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145706007152

Pharmacogenetics of tardive dyskinesia: combined analysis of 780 patients supports association with dopamine D3 receptor gene Ser9Gly polymorphism

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145706007152

Plasma glycine and serine levels in schizophrenia compared to normal controls and major depression: relation to negative symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145706007152

D2 receptors binding potential is not affected by Taq1 polymorphism at the D2 receptor gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145706007152

A rapid non-enzymatic method for the preparation of HMW DNA from blood for RFLP studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145706007152

Tardive dyskinesia: review and update

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145706007152

Relationship between adverse effects of antipsychotic treatment and dopamine D(2) receptor polymorphisms in patients with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145706007152

Polymorphisms in the dopamine D2 receptor gene and their relationships to striatal dopamine receptor density of healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145706007152

Lower incidence of tardive dyskinesia with risperidone compared with haloperidol in older patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145706007152

Association between a polymorphism in the promoter region of the dopamine D2 receptor gene and schizophrenia in Japanese subjects: replication and evaluation for antipsychotic-related features.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145706007152

Association between three functional polymorphisms of dopamine D2 receptor gene and tardive dyskinesia in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145706007152

Association analysis between two functional dopamine D2 receptor gene polymorphisms and schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145706007152

C957T polymorphism of the dopamine D2 receptor (DRD2) gene affects striatal DRD2 availability in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145706007152

Association with persistent neuroleptic-induced dyskinesia of regional changes in brain GABA synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145706007152

Distinct functions of the two isoforms of dopamine D2 receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145706007152

Improving outcome in schizophrenia: the potential importance of EPS and neuroleptic dysphoria

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145706007152

Dopamine D3 receptor gene and tardive dyskinesia in Chinese schizophrenic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145706007152

The structure of haplotype blocks in the human genome

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145706007152

Intra- and interindividual epigenetic variation in human germ cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145706007152

Treatment of tardive dyskinesia

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145706007152

Dopamine D3-receptor gene variant and susceptibility to tardive dyskinesia in schizophrenic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145706007152

Pedigree disequilibrium tests for multilocus haplotypes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145706007152

Association and excess of transmission of a DRD2 haplotype in a sample of French schizophrenic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145706007152

Synonymous mutations in the human dopamine receptor D2 (DRD2) affect mRNA stability and synthesis of the receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145706007152

Association of dopaminergic and serotonergic genes with tardive dyskinesia in patients with chronic schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145706007152

Association between the serotonin 2A receptor gene and tardive dyskinesia in chronic schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145706007152

Association between the serotonin 2C receptor gene and tardive dyskinesia in chronic schizophrenia: additive contribution of 5-HT2Cser and DRD3gly alleles to susceptibility.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145706007152

Polymorphic variations in GSTM1, GSTT1, PgP, CYP2D6, CYP3A5, and dopamine D2 and D3 receptors and their association with tardive dyskinesia in severe mental illness

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145706007152

Polymorphisms of dopamine receptors and tardive dyskinesia among Chinese patients with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145706007152

Differential contribution of dopamine D2S and D2L receptors in the modulation of glutamate and GABA transmission in the striatum

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145706007152

Association of seven polymorphisms of the D2 dopamine receptor gene with brain receptor-binding characteristics

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145706007152

Lack of association between serotonin-2A receptor gene (HTR2A) polymorphisms and tardive dyskinesia in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145706007152

DNA methylation at the putative promoter region of the human dopamine D2 receptor gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145706007152

The A1 allele of the human D2 dopamine receptor gene predicts low D2 receptor availability in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145706007152

Expanding the 'central dogma': the regulatory role of nonprotein coding genes and implications for the genetic liability to schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145706007152

Association of the MscI polymorphism of the dopamine D3 receptor gene with tardive dyskinesia in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145706007152

Haploview: analysis and visualization of LD and haplotype maps

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145706007152

Antipsychotic-induced tardive dyskinesia and the Ser9Gly polymorphism in the DRD3 gene: a meta analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145706007152

A functional polymorphism in the promoter region of the dopamine D2 receptor gene is associated with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145706007152

A simple correction for multiple testing for single-nucleotide polymorphisms in linkage disequilibrium with each other

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145706007152

Allelic association of the D2 dopamine receptor gene with receptor-binding characteristics in alcoholism

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145706007152

Neurotoxicity associated with neuroleptic-induced oral dyskinesias in rats. Implications for tardive dyskinesia?

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145706007152

Identification and characterization of ANKK1: a novel kinase gene closely linked to DRD2 on chromosome band 11q23.1

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145706007152

Effects of melatonin on behavioral dopaminergic supersensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145706007152

Clinical implications of pharmacogenomics for tardive dyskinesia

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145706007152

Identifying risk factors for tardive dyskinesia among long-term outpatients maintained with neuroleptic medications. Results of the Yale Tardive Dyskinesia Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145706007152

Serotonin receptors: their key role in drugs to treat schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145706007152

Tardive drug-induced extrapyramidal syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145706007152

Association between a promoter polymorphism in the dopamine D2 receptor gene and schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145706007152

Lack of association between a functional polymorphism of the cytochrome P450 1A2 (CYP1A2) gene and tardive dyskinesia in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145706007152

Familial occurrence of tardive dyskinesia

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145706007152

Manganese superoxide dismutase gene polymorphism and schizophrenia: relation to tardive dyskinesia

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145706007152

7 January 2021

Distribution of D1- and D2-dopamine receptors, and dopamine and its metabolites in the human brain

1 reference

https://api.crossref.org/works/10.1017%2FS1461145706007152

7 January 2021

Prospective study of tardive dyskinesia in the elderly: rates and risk factors

1 reference

https://api.crossref.org/works/10.1017%2FS1461145706007152

7 January 2021

Tardive dyskinesia: who is at risk?

1 reference

https://api.crossref.org/works/10.1017%2FS1461145706007152

7 January 2021

Racial variation in antidepressant treatment in a Medicaid population

1 reference

https://api.crossref.org/works/10.1017%2FS1461145706007152

7 January 2021

D2 dopamine receptor gene (DRD2) Taq1 A polymorphism: reduced dopamine D2 receptor binding in the human striatum associated with the A1 allele.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145706007152

7 January 2021

Dopamine D2 receptor promoter polymorphism: no association with schizophrenia

1 reference

https://api.crossref.org/works/10.1017%2FS1461145706007152

7 January 2021

https://api.crossref.org/works/10.1017%2FS1461145706007152

1 reference

7 January 2021

Chronic olanzapine or sertindole treatment results in reduced oral chewing movements in rats compared to haloperidol

1 reference

https://api.crossref.org/works/10.1017%2FS1461145706007152

7 January 2021

The relationship between dopamine D2 receptor polymorphism at the Taq1 A locus and therapeutic response to nemonapride, a selective dopamine antagonist, in schizophrenic patients

1 reference

https://api.crossref.org/works/10.1017%2FS1461145706007152

7 January 2021

Insertion/deletion variant (−141C Ins/Del) in the 5′ regulatory region of the dopamine D2 receptor gene: lack of association with schizophrenia and bipolar affective disorder

1 reference

https://api.crossref.org/works/10.1017%2FS1461145706007152

7 January 2021

Genetic susceptibility to tardive dyskinesia among schizophrenia subjects: IV. Role of dopaminergic pathway gene polymorphisms

1 reference

https://api.crossref.org/works/10.1017%2FS1461145706007152

7 January 2021

Pharmacological options for the management of dyskinesias

1 reference

https://api.crossref.org/works/10.1017%2FS1461145706007152

7 January 2021

Association of TaqI A polymorphism of dopamine D2 receptor gene and tardive dyskinesia in schizophrenia

1 reference

https://api.crossref.org/works/10.1017%2FS1461145706007152

7 January 2021

Increase in caudate nuclei volumes of first-episode schizophrenic patients taking antipsychotic drugs

1 reference

https://api.crossref.org/works/10.1017%2FS1461145706007152

7 January 2021

Genotypic association between the dopamine D3 receptor and tardive dyskinesia in chronic schizophrenia

1 reference

https://api.crossref.org/works/10.1017%2FS1461145706007152

7 January 2021

Possible implications of the dopamine D(3) receptor in schizophrenia and in antipsychotic drug actions

1 reference

https://api.crossref.org/works/10.1017%2FS1461145706007152

7 January 2021

Randomised double-blind comparison of the incidence of tardive dyskinesia in patients with schizophrenia during long-term treatment with olanzapine or haloperidol

1 reference

https://api.crossref.org/works/10.1017%2FS1461145706007152

7 January 2021

Tardive dyskinesia in psychiatric patients with substance use disorders.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145706007152

7 January 2021

Predictors of tardive dyskinesia: results of a cross-sectional study in an outpatient population

1 reference

https://api.crossref.org/works/10.1017%2FS1461145706007152

7 January 2021

Smoking and movement disorders in psychiatric patients

1 reference

https://api.crossref.org/works/10.1017%2FS1461145706007152

7 January 2021

10.1017/S1461145706007152

Identifiers

DOI

0 references

1 reference

22 December 2017